Boston Trust Walden Corp Reduces Stock Holdings in Agilent Technologies, Inc. (NYSE:A)

Boston Trust Walden Corp lowered its stake in Agilent Technologies, Inc. (NYSE:A - Free Report) by 1.4% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 402,254 shares of the medical research company's stock after selling 5,753 shares during the quarter. Boston Trust Walden Corp owned 0.14% of Agilent Technologies worth $59,727,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. First Bank & Trust purchased a new position in shares of Agilent Technologies in the third quarter valued at approximately $201,000. PFG Investments LLC increased its position in shares of Agilent Technologies by 6.9% during the third quarter. PFG Investments LLC now owns 2,345 shares of the medical research company's stock worth $348,000 after purchasing an additional 152 shares in the last quarter. Forsta AP Fonden raised its stake in Agilent Technologies by 7.7% in the 3rd quarter. Forsta AP Fonden now owns 113,200 shares of the medical research company's stock valued at $16,808,000 after purchasing an additional 8,100 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its holdings in Agilent Technologies by 18.5% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,388 shares of the medical research company's stock valued at $3,907,000 after purchasing an additional 4,118 shares in the last quarter. Finally, Outlook Wealth Advisors LLC boosted its stake in Agilent Technologies by 9.7% during the 3rd quarter. Outlook Wealth Advisors LLC now owns 2,434 shares of the medical research company's stock worth $361,000 after purchasing an additional 215 shares during the last quarter. Institutional investors and hedge funds own 87.42% of the company's stock.

Analysts Set New Price Targets

A has been the subject of several recent research reports. TD Cowen increased their price target on Agilent Technologies from $153.00 to $160.00 and gave the company a "buy" rating in a report on Thursday, August 22nd. Wells Fargo & Company began coverage on Agilent Technologies in a report on Tuesday, August 27th. They set an "overweight" rating and a $157.00 price target on the stock. Evercore ISI upped their price objective on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an "in-line" rating in a report on Tuesday, October 1st. Bank of America raised their price objective on shares of Agilent Technologies from $140.00 to $147.00 and gave the stock a "neutral" rating in a research report on Thursday, August 22nd. Finally, Citigroup boosted their target price on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a "buy" rating in a report on Thursday, August 22nd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and nine have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $144.36.

Insider Activity at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,958 shares of the firm's stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total transaction of $283,910.00. Following the transaction, the chief executive officer now directly owns 24,118 shares in the company, valued at approximately $3,497,110. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, CEO Padraig Mcdonnell sold 1,958 shares of the firm's stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.00. Following the transaction, the chief executive officer now owns 24,118 shares of the company's stock, valued at $3,497,110. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, SVP Dominique Grau sold 9,990 shares of the company's stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the sale, the senior vice president now directly owns 40,011 shares of the company's stock, valued at approximately $5,801,595. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 11,995 shares of company stock valued at $1,739,510 in the last three months. 0.33% of the stock is currently owned by company insiders.

Agilent Technologies Stock Down 0.4 %

NYSE A traded down $0.50 on Friday, hitting $130.19. 1,248,591 shares of the stock were exchanged, compared to its average volume of 1,685,121. Agilent Technologies, Inc. has a fifty-two week low of $96.80 and a fifty-two week high of $155.35. The company has a 50-day moving average price of $140.53 and a 200-day moving average price of $138.43. The company has a quick ratio of 1.37, a current ratio of 1.78 and a debt-to-equity ratio of 0.36. The company has a market cap of $37.98 billion, a PE ratio of 30.78, a PEG ratio of 6.96 and a beta of 1.05.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings data on Wednesday, August 21st. The medical research company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.06. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The business had revenue of $1.58 billion during the quarter, compared to analysts' expectations of $1.56 billion. During the same period in the prior year, the firm posted $1.43 EPS. The business's quarterly revenue was down 5.6% compared to the same quarter last year. Sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st were issued a $0.236 dividend. This represents a $0.94 annualized dividend and a dividend yield of 0.73%. The ex-dividend date of this dividend was Tuesday, October 1st. Agilent Technologies's payout ratio is currently 22.22%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.